Chemotherapy-Induced Peripheral Neuropathy is a frequent, dose-dependent complication of anticancer drugs, including platinum, taxanes, epothilones, vinca alkaloids, and newer agents.
Chemotherapy-Induced Peripheral Neuropathy Epidemiological Segmentation
The Epidemiological Segmentation of Chemotherapy-Induced Peripheral Neuropathy in 7MM from 2018 to 2030 is segmented as:-
- Total Incident Population of Chemotherapy-Induced Peripheral Neuropathy
- Incident Population of CIPN by Chemotherapeutic Agents
- Severity Specific Incidence of Chemotherapy-Induced Peripheral Neuropathy
- Incident Population of CIPN by Cancer Type
Chemotherapy-Induced Peripheral Neuropathy Epidemiology
- The total prevalent population of Chemotherapy-Induced Peripheral Neuropathy in 7MM in 2018 was 1,522,437
- The total number of CIPN prevalent cases in the United States was found to be 635,154.
- Germany had a total of 170,283 Chemotherapy-Induced Peripheral Neuropathy cases.
- The total number of CIPN cases in the United Kingdom was estimated to be 126,282.
- The total Chemotherapy-Induced Peripheral Neuropathy prevalent cases in Spain were 76,599.
- In Japan, the total number of CIPN prevalent cases was observed to be 270,556.
Chemotherapy-Induced Peripheral Neuropathy Market
The therapeutic market size of Chemotherapy-Induced Peripheral Neuropathy in 7MM in 2020 was USD 1,435.67 million.
Chemotherapy-Induced Peripheral Neuropathy Market Drivers
- Increasing emerging therapies
- Increasing awareness
Chemotherapy-Induced Peripheral Neuropathy Market Barriers
- No standard assessment
- Current therapy limitations
- Herbal remedies
- Clinical understanding
Chemotherapy-Induced Peripheral Neuropathy Emerging Drugs
The emerging drugs of the CIPN market are:
- SP-04 (PledOx)
- Tetrodotoxin or TTX
- E-52862
- ART-123 (Thrombomodulin alfa)
- MN-166 (Ibudilast)
- KRN 5500
- Niagen
- TRK-750
and many others.
Chemotherapy-Induced Peripheral Neuropathy Key Players
The key players in the CIPN market are:
- Solasia/PledPharma
- WEX Pharmaceuticals
- Laboratorios Dr. Esteve S.A. (ESTEVE)
- Asahi Kasei Pharma
- MediciNova
- DARA BioSciences
- ChromaDex
- Toray Industries
and many others.
Follow our blogs to get more insights into Chemotherapy-induced Peripheral Neuropathy market landscape